Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, May 2006, p. 1881-1883, Vol. 50, No. 5
0066-4804/06/$08.00+0 doi:10.1128/AAC.50.5.1881-1883.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Effect of a Nutritional Supplement on Posaconazole Pharmacokinetics following Oral Administration to Healthy Volunteers
Angela Sansone-Parsons,1*
Gopal Krishna,1
Angela Calzetta,1
David Wexler,1
Bhavna Kantesaria,1
Mitchell A. Rosenberg,2 and
Marc A. Saltzman2
Schering-Plough Research Institute, Kenilworth, New Jersey,1
Parkway Research Center, Inc., North Miami, Florida2
Received 3 October 2005/
Returned for modification 7 November 2005/
Accepted 13 February 2006
We conducted a randomized, crossover study in healthy adults to examine the effects of a nutritional supplement (Boost Plus) on posaconazole pharmacokinetics. In this study, coadministration of posaconazole with Boost Plus increased the maximum concentration of posaconazole in serum and area under the concentration-time curve from 0 to 72 h values 3.4- and 2.6-fold, respectively, compared to those for the fasted state.
* Corresponding author. Mailing address: Schering-Plough Research Institute, K-15-4-4455, 2015 Galloping Hill Rd., Kenilworth, NJ 07033. Phone: (908) 740-4093. Fax: (908) 740-2169. E-mail:
angela.sansone{at}spcorp.com.
Antimicrobial Agents and Chemotherapy, May 2006, p. 1881-1883, Vol. 50, No. 5
0066-4804/06/$08.00+0 doi:10.1128/AAC.50.5.1881-1883.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Krishna, G., Ma, L., Vickery, D., Yu, X., Wu, I., Power, E., Beresford, E., Komjathy, S.
(2009). Effect of Varying Amounts of a Liquid Nutritional Supplement on the Pharmacokinetics of Posaconazole in Healthy Volunteers. Antimicrob. Agents Chemother.
53: 4749-4752
[Abstract]
[Full Text]
-
Wohlt, P. D., Zheng, L., Gunderson, S., Balzar, S. A., Johnson, B. D., Fish, J. T.
(2009). Recommendations for the use of medications with continuous enteral nutrition. Am J Health Syst Pharm
66: 1458-1467
[Abstract]
[Full Text]
-
Dodds Ashley, E. S., Varkey, J. B., Krishna, G., Vickery, D., Ma, L., Yu, X., Malavade, D., Goodwin, M., Perfect, J. R., Power, E.
(2009). Pharmacokinetics of Posaconazole Administered Orally or by Nasogastric Tube in Healthy Volunteers. Antimicrob. Agents Chemother.
53: 2960-2964
[Abstract]
[Full Text]
-
Krishna, G., Moton, A., Ma, L., Medlock, M. M., McLeod, J.
(2009). Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers. Antimicrob. Agents Chemother.
53: 958-966
[Abstract]
[Full Text]
-
Morris, M. I.
(2009). Posaconazole: A new oral antifungal agent with an expanded spectrum of activity. Am J Health Syst Pharm
66: 225-236
[Abstract]
[Full Text]
-
Hachem, R. Y., Langston, A. A., Graybill, J. R., Perfect, J. R., Pedicone, L. D., Patino, H., Raad, I. I.
(2008). Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment. J Antimicrob Chemother
62: 1386-1391
[Abstract]
[Full Text]
-
Sansone-Parsons, A., Krishna, G., Simon, J., Soni, P., Kantesaria, B., Herron, J., Stoltz, R.
(2007). Effects of Age, Gender, and Race/Ethnicity on the Pharmacokinetics of Posaconazole in Healthy Volunteers. Antimicrob. Agents Chemother.
51: 495-502
[Abstract]
[Full Text]